Table 1 |
|
|
Clinical characteristics of simulated cohort |
|
| Parameter |
Value |
|
|
|
| Age (years) |
|
| Mean |
58 |
| Range |
29–88 |
| Gender (% Female) |
38% |
| Race |
|
| Caucasian |
92% |
| Afro-Caribbean |
4% |
| Asian |
4% |
| Initial resulting HbA1c level (mean) |
|
| Metformin monotherapy |
7.6% |
| Combination therapy |
6.9% |
| HbA1c annual upward drift |
0.15% |
|
|
|
|
Ward et al. Cost Effectiveness and Resource Allocation 2004 2:2 doi:10.1186/1478-7547-2-2 |
|
